Treatment type: Precision medicine

  • Surviving childhood cancer – Luca’s story

    It’s hard to imagine four words more frightening to a parent than “Your child has cancer”. Amid the fear and panic such a sentence creates, three-year-old Luca’s parents, Monique and Baden, had little choice but to trust in the best that medical science could offer.…  Read more

    Luca Boggia rare brain tumor survivor playing in a park and laughing
  • Surviving rare childhood brain cancers

    There’s nothing in Luca Hall-Boggia’s winning smile or cheeky attitude to suggest the suffering he’s endured. You wouldn’t spot the small bald patch, amid his mess of dark, wavy hair, which is the only remaining evidence of the brain surgery that saved his life when he was just 3 years old.…  Read more

    Luca Hall-Boggia a cancer survivor smiling at Hudson Institute. Picture Courtesy Jason Edwards /Herald Sun
  • How the microbiome affects the immune system

    Shining a light on how the lung microbiome in the first days of life can affect the immune system for years to come, Hudson Institute researchers have taken an important first step in an increasingly relevant field of medical study.…  Read more

    Claudia Nold, Marcel Nold, Sara di Simone, Sam Forster and Ina Rudloff in the lab at Hudson Insitute
  • Curing childhood cancer: all roads lead to Melbourne

    A single laboratory in south-east Melbourne is now the global hub for medical researchers looking to cure childhood cancer.…  Read more

    Dr Paul Daiel and Dr Claire Sun at Hudson Institute working on curing childhood cancer.
  • Lymphoma treatment targets multiple diseases

    The search for new therapies to treat a rare type of non-Hodgkins lymphoma has had an unexpected success – identifying a potential molecular target to treat other related forms of lymphoma as well.…  Read more

    Tissue section from a pre-clinical model in which precancerous lesions of stomach lymphoma are seen to be predominantly composed of B cells (green) and surrounded by different types of immune cells (red, yellow). Image provided by Dr Ying.
  • Pancreatitis treatment target offers new hope

    It’s a disease in search of a remedy, but Hudson Institute researchers have identified a new pancreatitis treatment target, giving hope to sufferers worldwide.…  Read more

    Scientist, Dr Mohamed Saad identifies a new pancreatitis treatment target, giving hope to sufferers worldwide.
  • Engineering a better POP treatment option

    People living with pelvic organ prolapse (POP) have had a limited number of treatments available to them over the years, so a new POP treatment option can be a cause for excitement.…  Read more

    Smart POP pessary team
  • Introducing POP advocate – Sally Maconochie

    It’s a condition that is rarely spoken about, but one Australian woman has set out to change that – meet Hudson Institute’s new pelvic organ prolapse (POP) advocate, Sally Maconochie.…  Read more

    Sally Maconochie POP advocate.
  • Hudson Institute welcomes childhood cancer pledge

    As a global leader in the field of childhood cancer research, Hudson Institute of Medical Research welcomes the Victorian Government’s pledge to invest $35 million in this area of vital need.…  Read more

    Children like Lachy and their families will benefit from VPCC's childhood cancer research.
  • Finding a cause of high blood pressure

    After watching her father struggle with hypertension (high blood pressure) for decades, endocrinologist Dr Jun Yang found he had a hormonal condition called primary aldosteronism (PA).…  Read more

    Dr Jun Yang and her father Lisheng Yang at Hudson Institute